Drug Trial Radar · NCT03541174
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
Last checked: Nov 19, 2026Latest source record: Mar 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
730
Actual
Start
Jun 18, 2018
Primary completion
May 14, 2021
Study completion Apr 25, 2022
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Janssen Biotech, Inc.
- First posted
- May 30, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.
Conditions
- Resistant Hypertension
Interventions
Aprocitentan 12.5 mgDrug
Tablet, oral use
Aprocitentan 25 mgDrug
Tablet, oral use
PlaceboDrug
Matching placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 4 of Double-blind Treatment in Mean Trough Sitting Systolic Blood Pressure (SiSBP) Measured by Automated Office Blood Pressure MeasurementTime frame: Pre-dose Day 1 (Part 1 double-blind randomized baseline) up to Week 4 (End of double-blind randomized part 1)
Locations
159 sites in 20 countries. Site status is shown where the registry gives one.
Advanced Cardiovascular, LLC
Alexander City, Alabama
Chrishard Medical Group
Inglewood, California
Clinical Trials Research
Lincoln, California
Academic Medical Research Institute Inc
Los Angeles, California
Amicis Research Center
Northridge, California
California Kidney Specialists
San Dimas, California
Bay Area Cardiology Associates, P.A.
Brandon, Florida
Century Clinical Research, Inc
Daytona Beach, Florida
Mayo Clinic Jacksonville
Jacksonville, Florida
Canvas Clinical Research, LLC
Lake Worth, Florida
East Coast Institute for Research
Saint Augustine, Florida
Premier Medical Associates
The Villages, Florida
SIU School of Medicine Center for Clinical Research
Springfield, Illinois
Midwest Institute for Clinical Research
Indianapolis, Indiana
Cardiovascular Research of Northwest Indiana, L.L.C.
Munster, Indiana
Reid Physician Associates
Richmond, Indiana
Grace Research, LLC
Bossier City, Louisiana
MedStar Health Research Institute
Hyattsville, Maryland
Clinical Research Consultants, LLC
Kansas City, Missouri
Hypertension and Nephrology Association PA
Eatontown, New Jersey
Renal Medicine Associates
Albuquerque, New Mexico
Albany Medical College
Albany, New York
Scott Research Inc
Laurelton, New York
Great Lakes Medical Research LLC
Westfield, New York
Metrolina Internal Medicine/Internal Medicine Research
Charlotte, North Carolina
East Carolina University
Greenville, North Carolina
Physician's East Endocrinology
Greenville, North Carolina
Carteret Medical Group
Morehead City, North Carolina
University Hospitals Cleveland Medical Center - Neurological Institute
Cleveland, Ohio
Willamette Valley Clinical Studies
Eugene, Oregon
TLM Medical Services LLC
Columbia, South Carolina
DeGarmo Institute of Medical Research
Greer, South Carolina
Stern Cardiovascular Foundation, Inc
Germantown, Tennessee
LifeDOC Research PLLC
Memphis, Tennessee
Amarillo Heart Clinical Research Institute, Inc.
Amarillo, Texas
LinQ Research, LLC
Pearland, Texas
Mercury Clinical Research
Webster, Texas
St. George Kidney Care LLC dba Southern Utah Kidney and Hypertension Center
St. George, Utah
Burke Internal Medicine & Research
Burke, Virginia
Manassas Clinical Research Center
Manassas, Virginia
Showing 40 of 159 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.